Antimicrobial therapy of anaerobic infections: a status report.
D000196:Actinomycosis / Q000188:drug therapy; D000900:Anti-Bacterial Agents / Q000494:pharmacology / Q000627:therapeutic use*; D001424:Bacterial Infections / Q000188:drug therapy*; D001431:Bacteriological Techniques; D001442:Bacteroides Infections / Q000188:drug therapy; D003015:Clostridium Infections / Q000188:drug therapy; D004352:Drug Resistance, Microbial; D006089:Gram-Negative Anaerobic Bacteria / Q000187:drug effects / Q000302:isolation & purification; D006801:Humans; D008795:Metronidazole / Q000494:pharmacology / Q000627:therapeutic use; D065093:beta-Lactamase Inhibitors
D000900:Anti-Bacterial Agents; D065093:beta-Lactamase Inhibitors; D008795:Metronidazole